Smart Money Alert
Sai Life Sciences Limited
New PositionBlock Deal
SAILIFEPharmaceuticalsMarket Cap₹33K Cr
Value
₹80.92 Cr
Shares
7,96,916
Price
₹1,015.4
Morgan Stanley
Foreign Investor
The move
Morgan Stanley bought 7,96,916 shares of Sai Life Sciences for ₹80.92 Cr at ₹1015.40 apiece in a block deal.
About Sai Life Sciences Limited
Visit stock A contract research and manufacturing organization serving the pharmaceutical and biotechnology industries, Sai Life Sciences conducts research activities and produces customized solutions for clients globally. Incorporated in 1999, the company operates as a specialized service provider, offering integrated capabilities across drug development, formulation, and manufacturing to support its customers' product pipelines and commercial operations in India and international markets.
About Morgan Stanley
Visit investor US-based global investment bank. India FPI activity covers proprietary, market-making and client flows in listed Indian equities.
Get the next move the moment it happens.
Follow Morgan Stanley and Sai Life Sciences Limited on WhaleWatch, alongside 300+ top investors, funds and FPIs. The newest moves are waiting for you inside.
🤖 We track their every move, post, interview and article. Obsessively.
⚡ Every move reaches your feed in minutes, while it still carries an edge
📊 Stake changes, bulk deals and insider trades, all tracked in one place
📰 A two-minute morning brief, so you start the day already ahead
HDFC Mutual FundExited
HDFC Mutual Fund, which previously held 1.02 percent of Sai Life Sciences Limited, is no longer listed among its named shareholders, indicating either a complete sale or a reduction in its stake to below the 1 percent disclosure requirement.
21 Jul 2026
Read more Max Life Insurance
Direction, size, price and stake change for this move, with what it means for the company.
21 Jul 2026. Sign in to see this move
Axis Mutual FundDecreased
Axis Mutual Fund decreased its stake in Sai Life Sciences from 2.94% to 2.90% by selling 65,460 shares.
21 Jul 2026
Read more Nippon India Mutual FundIncreased
Nippon India Mutual Fund increased its stake in Sai Life Sciences from 6.16% to 6.66% by purchasing 1,107,966 shares. This position increase is valued at approximately ₹157.57 crore based on the share price of ₹1422.20.
21 Jul 2026
Read more Invesco Mutual FundIncreased
Invesco Mutual Fund increased its stake in Sai Life Sciences from 7.27% to 7.44% by purchasing 390,619 shares. The additional shares are valued at ₹55.56 crore, based on the current share price of ₹1422.20.
21 Jul 2026
Read more Meesho Limited
Direction, size, price and stake change for this move, with what it means for the company.
23 Sept 2026. Sign in to see this move
Pine Labs LimitedNew position
Morgan Stanley bought 13,50,001 shares of Pine Labs Limited for ₹25.35 Cr at ₹187.75 apiece in a block deal.
PINELABS22 Sept 2026
Read more Sri Lotus Developers and Realty LimitedNew position
Morgan Stanley bought 15 lakh shares of Sri Lotus Developers and Realty Limited for ₹30.26 Cr at ₹201.75 apiece in a block deal.
LOTUSDEV11 Sept 2026
Read more Meesho LimitedNew position
Morgan Stanley bought 33 lakh shares of Meesho Limited for ₹68.08 Cr at ₹206.30 apiece in a block deal.
MEESHO3 Sept 2026
Read more Pine Labs LimitedNew position
Morgan Stanley bought 24,48,742 shares of Pine Labs Limited for ₹37.98 Cr at ₹155.10 apiece in a block deal.
PINELABS2 Sept 2026
Read more